Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies

Fig. 2

Patient disposition and flow in (a) study A and (b) study B. PK = pharmacokinetic; PP = per protocol. aOne volunteer withdrew prior to the first dose and was replaced by a reserve volunteer as per the protocol

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us